Choosing topical corticosteroids

American Family Physician

Volumn 79, Issue 2, 2009, Pages 135-140

  Ference, Jonathan D ^a,c   Last, Allen R ^b  

^a WILKES UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c Nesbitt College of Pharmacy and Nursing   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCLOMETASONE DIPROPIONATE; AMCINONIDE; APEXICON; BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; BETANATE; BUDESONIDE; CINALOG; CLOBETASOL PROPIONATE; CLOBEX; CORTICOSTEROID; DESONATE; DESONIDE; DESOXIMETASONE; DIFLORASONE DIACETATE; DRUG VEHICLE; FLUDROXYCORTIDE; FLUOCINOLONE; FLUOCINOLONE ACETONIDE; FLUOCINONIDE; FLUTICASONE PROPIONATE; HALCINONIDE; HYDROCORTISONE; HYDROCORTISONE 17 BUTYRATE 21 PROPIONATE; HYDROCORTISONE BUTYRATE; HYDROCORTISONE VALERATE; LOKARA; LUXIQ; MOMETASONE FUROATE; RETINOIC ACID; TRIAMCINOLONE ACETONIDE; TRIDERM; ULOBETASOL PROPIONATE; UNCLASSIFIED DRUG; VANOS; VERDESO; DERMATOLOGICAL AGENT;

ACNE; ALOPECIA AREATA; ANUS DISEASE; ASEPTIC NECROSIS; ATOPIC DERMATITIS; BACTERIAL INFECTION; BULLOUS PEMPHIGOID; CATARACT; CHLOASMA; CONTACT DERMATITIS; CUSHING DISEASE; DERMATITIS; DIAPER DERMATITIS; DISCOID LUPUS ERYTHEMATOSUS; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; ECZEMA; ERYTHEMA; EYELID DERMATITIS; FACE DERMATITIS; GLAUCOMA; GRANULOMA; GROWTH RATE; HIRSUTISM; HUMAN; HYPERGLYCEMIA; HYPERPIGMENTATION; HYPERTENSION; HYPERTRICHOSIS; HYPOCALCEMIA; HYPOPIGMENTATION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTERTRIGO; INTRAOCULAR HYPERTENSION; KAPOSI SARCOMA; LICHEN PLANUS; LICHEN SCLEROSUS ET ATROPHICUS; MYCOSIS; NEURODERMATITIS; NUMMULAR DERMATITIS; PATIENT SATISFACTION; PEMPHIGUS FOLIACEUS; PERIORAL DERMATITIS; PERIPHERAL EDEMA; PHIMOSIS; PHOTOSENSITIVITY DISORDER; PSORIASIS; PURPURA; PUSTULE; PUSTULOSIS; RADIATION DERMATITIS; RASH; REVIEW; ROSACEA; SCABIES; SEBORRHEIC DERMATITIS; SECONDARY INFECTION; SIDE EFFECT; SKIN ATROPHY; SKIN BRUISING; SKIN FRAGILITY; SKIN INFECTION; SKIN IRRITATION; SKIN SCAR; SKIN ULCER; STRIA; TACHYPHYLAXIS; TELANGIECTASIA; TINEA; TREATMENT DURATION; TREATMENT INDICATION; URTICARIA; VITILIGO; WOUND HEALING; ARTICLE; SKIN DISEASE; TOPICAL DRUG ADMINISTRATION; VEHICLES;

ADMINISTRATION, TOPICAL; ADRENAL CORTEX HORMONES; DERMATOLOGIC AGENTS; HUMANS; SKIN DISEASES; VEHICLES;

EID: 60249103113     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Marsland AM, Chalmers RJ, Hollis S, Leonardi-Bee J, Griffiths CE. Interventions for chronic palmoplantar pustulosis. Cochrane Database Syst Rev. 2006;(1):CD001433.
2. Lepe V, Moncada B, Castanedo-Cazares JP, Torres-Alvarez MB, Ortiz CA, Torres-Rubalcava AB. A double-blind randomized trial of 0.1% tacrolimus vs. 0.05% clobetasol for the treatment of childhood vitiligo. Arch Dermatol. 2003;139(5):581-585. (Pubitemid 36576373)
3. Handa S, Pandhi R, Kaur I. Vitiligo: a retrospective comparative analysis of treatment modalities in 500 patients. J Dermatol. 2001;28(9):461-466. (Pubitemid 32958760)
4. Renaud-Vilmer C, Cavelier-Balloy B, Porcher R, Dubertret L. Vulvar lichen sclerosus: effect of long-term topical application of a potent steroid on the course of the disease. Arch Dermatol. 2004;140(6):709-712. (Pubitemid 38747287)
5. Dumas V, Roujeau JC, Wolkenstein P, Revuz J, Cosnes A. The treatment of mild pemphigus vulgaris and pemphigus foliaceus with a topical corticosteroid. Br J Dermatol. 1999;140(6):1127-1129. (Pubitemid 29284588)
6. Joly P, Roujeau JC, Benichou J, et al., for the Bullous Diseases French Study Group. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med. 2002;346(5):321-327.
7. Tosti A, Iorizzo M, Botta GL, Milani M. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial. J Eur Acad Dermatol Venereol. 2006;20(10):1243-1247. (Pubitemid 44614622)
8. Charuwichitratana S, Wattanakrai P, Tanrattanakorn S. Randomized double-blind placebo-controlled trial in the treatment of alopecia areata with 0.25% desoximetasone cream. Arch Dermatol. 2000;136(10):1276-1277. (Pubitemid 30776138)
9. Tan MH, Meador SL, Singer G, Lebwohl MG. An open-label study of the safety and efficacy of limited application of fluticasone propionate ointment, 0.005%, in patients with atopic dermatitis of the face and intertriginous areas. Int J Dermatol. 2002;41(11):804-809. (Pubitemid 35422852)
10. Hanifin J, Gupta AK, Rajagopalan R. Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients. Br J Dermatol. 2002;147(3):528-537. (Pubitemid 35015290)
11. Lund L, Wai KH, Mui LM, Yeung CK. Effect of topical steroid on nonretractile prepubertal foreskin by a prospective, randomized, doubleblind study. Scand J Urol Nephrol. 2000;34(4):267-269. (Pubitemid 32061335)
12. Lund L, Wai KH, Mui LM, Yeung CK. An 18-month follow-up study after randomized treatment of phimosis in boys with topical steroid versus placebo. Scand J Urol Nephrol. 2005;39(1):78-81. (Pubitemid 40380449)
13. Schmuth M, Wimmer MA, Hofer S, et al. Topical corticosteroid therapy for acute radiation dermatitis: a prospective, randomized, double-blind study. Br J Dermatol. 2002;146(6):983-991. (Pubitemid 34779478)
14. Shukla PN, Gairola M, Mohanti BK, Rath GK. Prophylactic beclamethasone spray to the skin during postoperative radiotherapy of carcinoma breast: a prospective randomized study. Indian J Cancer. 2006;43(4):180-184.
15. Sarkar R, Bhalla M, Kanwar AJ. A comparative study of 20% azelaic acid cream monotherapy versus a sequential therapy in the treatment of melasma in dark-skinned patients. Dermatology. 2002;205(3):249-254. (Pubitemid 36158535)
16. Ellingsen AR, Thestrup-Pederson K. Treatment of chronic idiopathic urticaria with topical steroids. An open trial. Acta Derm Venereol. 1996;76(1):43-44. (Pubitemid 26090868)
17. Mancini AJ, Frieden IJ, Paller AS. Infantile acropustulosis revisited: history of scabies and response to topical corticosteroids. Pediatr Dermatol. 1998;15(5):337-341. (Pubitemid 28465800)
18. Myers JB, Sorensen CM, Wisner BP, Furness PD 3rd, Passamaneck M, Koyle MA. Betamethasone cream for the treatment of pre-pubertal labial adhesions. J Pediatr Adolesc Gynecol. 2006;19(6):407-411.
19. Wilson DE, Kaidbey K, Boike SC, Jorkasky DK. Use of topical corticosteroid pretreatment to reduce the incidence and severity of skin reactions associated with testosterone transdermal therapy. Clin Ther. 1998;20(2):299-306. (Pubitemid 28241750)
20. Pariser DM. Topical steroids: a guide for use in the elderly patient. Geriatrics. 1991;46(10):51-54,57-60,63.
21. Drake LA, Dinehart SM, Farmer ER, et al. Guidelines of care for the use of topical glucocorticosteroids. J Am Acad Dermatol. 1996;35(4):615-619. (Pubitemid 26427069)
22. Goa KL. Clinical pharmacology and pharmacokinetic properties of topically applied corticosteroids. A review. Drugs. 1988;36(suppl 5):51-61. (Pubitemid 19175860)
23. McKenzie AW. Comparison of steroids by vasoconstriction. Br J Dermatol. 1966;78(3):182-183.
24. Facts and Comparisons 4.0. http://www.factsandcomparisons.com (password required). Accessed February 10, 2008.
25. Olsen EA. A double-blind controlled comparison of generic and tradename topical steroids using the vasoconstriction assay. Arch Dermatol. 1991;127(2):197-201.
26. Geraci AC, Crane JS, Cunha BA. Topical steroids: dosing forms and general considerations. Hosp Pharm. 1991;26:699-719.
27. du Vivier A. Tachyphylaxis to topically applied steroids. Arch Dermatol. 1976;112(9):1245-1248.
28. Long CC, Finaly AY. The finger-tip unit - a new practical measure. Clin Exp Dermatol. 1991;16(6):444-447.
29. Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54(1):1-15. (Pubitemid 41832453)
30. McMicheal AJ, Griffiths CE, Talwar HS, et al. Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy. Br J Dermatol. 1996;135(1):60-64. (Pubitemid 26225116)
31. Alston SJ, Cohen BA, Braun M. Persistent and recurrent tinea corporis in children treated with combination antifungal/corticosteroid agents. Pediatrics. 2003;111(1):201-203. (Pubitemid 36071055)